Pulmonary: Page 2

Cutting-edge pneumonia classification
Scientists analyzed human lungs to uncover seven subgroups of the widespread respiratory disease.
May 14, 2026
Getty Images 1086669200
Infectious bacteria observed in chronic lung, sinus diseases
People with both conditions are at increased risk of Pseudomonas aeruginosa — a persistent bacteria.
May 14, 2026
Getty Images 2211879284
A potential cure for severe CF mutation
Gene editing therapy could be the ultimate solution for patients with a difficult-to-treat form of cystic fibrosis.
May 7, 2026
Getty Images 1316503044
Sponsored
Advocate for better air
Ascend Media
The ALA’s State of the Air report provides rankings and recommendations.
November 19, 2025
Advocate for better air
Exploration of lung scarring reversal
An experimental drug targeting ID1 and ID3 could both halt and undo damage caused by pulmonary fibrosis.
May 5, 2026
(From left) Assistant professor Yassine Sassi, PhD, postdoctoral associate Samar Antar and research associate Jacob Dahlka.
Lung scan differences help signal sarcoidosis severity
Analytic findings could lead to improved classification, disease prediction and personalized care plans.
May 1, 2026
A. Nonfibrotic sarcoidosis; B. Fibrotic sarcoidosis
A new target to alleviate PAH
Japanese scientists demonstrated the role of CNP/GC-B signaling and suggest supplemental therapy to prevent or slow disease progression.
April 29, 2026
Proposed role of CNP/GC-B signaling in PAH. In PAH, expression of CNP and its receptor GC-B is reduced in the pulmonary vasculature. Endothelial cell-specific CNP or GC-B knockout mice, but not smooth muscle cell-specific GC-B knockout mice, showed more severe PH in mice. Administration of CNP activates endothelial GC-B signaling, which suppresses endothelin-1, inflammatory cytokines and SMAD imbalance, thereby attenuating pulmonary vascular remodeling and disease progression.
Sponsored
Advocate for better air
Ascend Media
The ALA’s State of the Air report provides rankings and recommendations.
November 19, 2025
Advocate for better air
Hiding in plain sight
Research reveals how rare lung cancers with mixed tumor features can progress and transform.
April 23, 2026
Getty Images 2207680068
Human airway models could pave way for improved devices, therapies
A computational study illustrates the need for patient-specific modeling to treat certain pulmonary conditions.
April 23, 2026
Getty Images 2212325776
Inhaled treprostinil reduces FVC decline
Trial meets primary and secondary endpoints in the treatment of idiopathic pulmonary fibrosis in adults.
April 17, 2026
Getty Images 2163709292
Sponsored
Advocate for better air
Ascend Media
The ALA’s State of the Air report provides rankings and recommendations.
November 19, 2025
Advocate for better air
‘Molecular map’ of key cardiopulmonary receptor
Unprecedented images of thromboxane A2 reveal surprising findings of the receptor’s role in inflammation, blood clotting and more.
April 17, 2026
Figure 1: Active state structures and functional characterization of the thromboxane A2 receptor (TP).*
PH algorithm gets FDA clearance
The AI-enabled software works with ECGs to detect early signs of pulmonary hypertension.
April 10, 2026
Getty Images 2147721018
A ‘breathable’ human lung organoid
Researchers developed the 3D system to measure lung expansion and study pulmonary disease.
April 10, 2026
Conceptual illustration comparing the structure of pulmonary aciniform organoids (PAcinOs) with the human pulmonary acinus. Pressure-induced PAcinO expansion mimics the inspiratory motion of alveolar sacs.
Previous Page
Page 2 of 27
Next Page
Most Popular
The impact of cellular organization in asthma
AI could streamline care for COPD, asthma
Combination drug therapy could improve cystic fibrosis
Targeting a dual health challenge
Large UK trial to transform treatment for severe childhood asthma
Advancement in lung cancer treatment approach